If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) ...

A large study of 30,000 adults diagnosed with ADHD in the U.K. found women with ADHD died roughly nine years younger than women without a diagnosis. Men had about a seven-year shorter lifespan.

Spravato, okayed for stand-alone use among adults, is the first such therapy for major depressive disorder (MDD) that is ...

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says.Vaccines, ...

Broad classes of drugs, including antibiotics, antivirals, vaccines, anti-inflammatories and antihypertensives, were ...

By Dr. Brittney Gray University of Kentucky Bringing a baby into the world is often portrayed as one of life’s happiest ...

For more audio journalism and storytelling, download New York Times Audio, a new iOS app available for news subscribers. Hosted by Sabrina Tavernise Featuring Coral Davenport Produced by Rob ...